Results from both model 1 (adjusted for age and sex) and 2 (further adjusted for eGFR, HCY, uric acid, Hs-CRP) (Table 3) showed that the relationship between plasma ceramide levels (Cer18:0, Cer20:0, Cer22:0, and Cer24:1) and ACS-MS group was significant with p-values close to 0.000 (95% CI) and that there was a mild relationship between Cer16:0 and ACS-MS group with a p-value of 0.013 for model 1 and 0.026 for model 2. This evidence concerns the gene MAP3K14 and myeloid sarcoma.